DCF — THOMASVILLE MEDICAL CENTER
Enterprise Value: $-479.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-479.4M
Enterprise Value
$-149.2M
PV of Cash Flows
$-330.2M
PV of Terminal Value
$-531.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $226.9M | $-31.2M | -14.0% | $-40.8M | $-37.1M |
| Year 2 | $233.7M | $-29.8M | -13.0% | $-39.7M | $-32.8M |
| Year 3 | $240.7M | $-28.3M | -12.0% | $-38.5M | $-28.9M |
| Year 4 | $247.9M | $-27.9M | -11.0% | $-38.4M | $-26.2M |
| Year 5 | $255.4M | $-28.1M | -11.0% | $-38.9M | $-24.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-479.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$220.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14252510060993248
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5